关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Shanxi

Release time:

2023-07-12

Product Name Specifications Packaging
Fenofibrate Capsules 0.2g 10 capsules/box
Fenofibrate Capsules 0.2g 20 capsules/box
Guipi Capsule 0.3g per capsule 24 capsules/box
Guipi Capsule 0.3g per capsule 36 capsules/box
Anetellithin Tablets 25mg 12pcs/box
Ambroxol Hydrochloride Capsules 60mg 24 capsules/box
Ambroxol Hydrochloride Capsules 60mg 12 capsules/box
Ambroxol Hydrochloride Capsules 30mg 36 capsules/box
Sodium ferulate for injection 0.1g 1 bottle/bottle
Sodium ferulate for injection 0.2g 1 bottle/bottle
Sodium ferulate for injection 0.3g 1 bottle/bottle
Sodium fructose diphosphate for injection 5g (as anhydrous) 1 bottle/bottle
Cefoxitin Sodium for Injection Based on C16H17N307S2 calculation 0.5g 1 bottle/bottle
Cefazolin Sodium for Injection 0.5g 1 stick/stick
Clindamycin hydrochloride for injection 0.15g 1 bottle/bottle
Clindamycin hydrochloride for injection 0.3g 1 bottle/bottle
Clindamycin hydrochloride for injection 0.6g 1 bottle/bottle
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs